Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 10

Results: 22

Tumour cell-activated platelets modulate the immunological activity of CD4+, CD8+, and NK cells, which is efficiently antagonized by heparin.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2523, doi. 10.1007/s00262-022-03186-5

By:

Gockel, Lukas M.;
Nekipelov, Katrin;
Ferro, Vito;
Bendas, Gerd;
Schlesinger, Martin

Publication type:

Article

Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2549, doi. 10.1007/s00262-022-03182-9

By:

Thibaudin, Marion;
Limagne, Emeric;
Hampe, Léa;
Ballot, Elise;
Truntzer, Caroline;
Ghiringhelli, Francois

Publication type:

Article

Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2535, doi. 10.1007/s00262-022-03181-w

By:

Samad, Abdus;
Meghla, Nigar Sultana;
Nain, Zulkar;
Karpiński, Tomasz M.;
Rahman, Md. Shahedur

Publication type:

Article

Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2565, doi. 10.1007/s00262-022-03179-4

By:

Löwenmark, Thyra;
Li, Xingru;
Löfgren-Burström, Anna;
Zingmark, Carl;
Ling, Agnes;
Kellgren, Therese G.;
Larsson, Pär;
Ljuslinder, Ingrid;
Wai, Sun Nyunt;
Edin, Sofia;
Palmqvist, Richard

Publication type:

Article

Immunosuppressive properties of human PD-1 + , PDL-1 + and CD80 + dendritic cells from lymph nodes aspirates of lung cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2469, doi. 10.1007/s00262-022-03178-5

By:

Kwiecień, Iwona;
Rutkowska, Elżbieta;
Raniszewska, Agata;
Sokołowski, Rafał;
Bednarek, Joanna;
Jahnz-Różyk, Karina;
Rzepecki, Piotr;
Domagała-Kulawik, Joanna

Publication type:

Article

Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2497, doi. 10.1007/s00262-022-03177-6

By:

Panaampon, Jutatip;
Kariya, Ryusho;
Okada, Seiji

Publication type:

Article

The nuclear transportation of PD-L1 and the function in tumor immunity and progression.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2313, doi. 10.1007/s00262-022-03176-7

By:

Qu, Liyan;
Jin, Jiakang;
Lou, Jianan;
Qian, Chao;
Lin, Jinti;
Xu, Ankai;
Liu, Bing;
Zhang, Man;
Tao, Huimin;
Yu, Wei

Publication type:

Article

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.

Published in:

2022

By:

Femel, Julia;
van Hooren, Luuk;
Herre, Melanie;
Cedervall, Jessica;
Saupe, Falk;
Huijbers, Elisabeth J. M.;
Verboogen, Danielle R. J.;
Reichel, Matthias;
Thijssen, Victor L.;
Griffioen, Arjan W.;
Hellman, Lars;
Dimberg, Anna;
Olsson, Anna-Karin

Publication type:

Correction Notice

Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2511, doi. 10.1007/s00262-022-03173-w

By:

Zhang, Hongyu;
Liu, Zilong;
Wen, Haoyu;
Guo, Yifan;
Xu, Fengkai;
Zhu, Qiaoliang;
Yuan, Wei;
Luo, Rongkui;
Lu, Chunlai;
Liu, Ronghua;
Gu, Jie;
Ge, Di

Publication type:

Article

Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2433, doi. 10.1007/s00262-022-03172-x

By:

Zhu, Guidong;
Zhang, Junwen;
Zhang, Qing;
Jin, Guishan;
Su, Xiaodong;
Liu, Sisi;
Liu, Fusheng

Publication type:

Article

CMTM6 as a master regulator of PD-L1.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2325, doi. 10.1007/s00262-022-03171-y

By:

Yaseen, Mahmoud Mohammad;
Abuharfeil, Nizar Mohammad;
Darmani, Homa

Publication type:

Article

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2421, doi. 10.1007/s00262-022-03170-z

By:

Sato, Yosuke;
Casson, Cierra N.;
Matsuda, Atsushi;
Kim, James I.;
Shi, Judy Qiuju;
Iwasaki, Shinji;
Chen, Susan;
Modrell, Brett;
Chan, Chingkit;
Tavares, Daniel;
Austen, Douglas;
Ida, Koh;
Tayber, Olga;
Hein, Pyae;
Comeau, Robert;
Lin, Yafang;
Shaw, Michael H.

Publication type:

Article

Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2405, doi. 10.1007/s00262-022-03169-6

By:

Shaikh, Fyza Y.;
Gills, Joell J.;
Mohammad, Fuad;
White, James R.;
Stevens, Courtney M.;
Ding, Hua;
Fu, Juan;
Tam, Ada;
Blosser, Richard L.;
Domingue, Jada C.;
Larman, Tatianna C.;
Chaft, Jamie E.;
Spicer, Jonathan D.;
Reuss, Joshua E.;
Naidoo, Jarushka;
Forde, Patrick M.;
Ganguly, Sudipto;
Housseau, Franck;
Pardoll, Drew M.;
Sears, Cynthia L.

Publication type:

Article

Correction to: Functional virus‑specific memory T cells survey glioblastoma.

Published in:

2022

By:

Ning, Jianfang;
Gavil, Noah V.;
Wu, Shaoping;
Wijeyesinghe, Sathi;
Weyu, Eyob;
Ma, Jun;
Li, Ming;
Grigore, Florina‑Nicoleta;
Dhawan, Sanjay;
Skorput, Alexander G. J.;
Musial, Shawn C.;
Chen, Clark C.;
Masopust, David;
Rosato, Pamela C.

Publication type:

Correction Notice

Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2449, doi. 10.1007/s00262-022-03167-8

By:

Qu, Li-Hua;
Fang, Qian;
Yin, Tong;
Yi, Hui-Mei;
Mei, Guang-Bo;
Hong, Zi-Zhan;
Qiu, Xue-Bing;
Zhou, Rui;
Dong, Hui-Fen

Publication type:

Article

Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2381, doi. 10.1007/s00262-022-03166-9

By:

Keber, Corinna U.;
Derigs, Marcus;
Schultz, Carolin;
Wegner, Moritz;
Lingelbach, Susanne;
Wischmann, Viktoria;
Hofmann, Rainer;
Denkert, Carsten;
Hegele, Axel;
Hänze, Jörg

Publication type:

Article

Transient 40 °C-shock potentiates cytotoxic responses of Vδ2+ γδ T cell via HSP70 upregulation.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2391, doi. 10.1007/s00262-022-03164-x

By:

Lin, Li;
Chen, Yan;
Chen, Dan;
Shu, Junxiang;
Hu, Yi;
Yin, Zhinan;
Wu, Yangzhe

Publication type:

Article

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2301, doi. 10.1007/s00262-022-03163-y

By:

Ormhøj, Maria;
Abken, Hinrich;
Hadrup, Sine R.

Publication type:

Article

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2371, doi. 10.1007/s00262-022-03160-1

By:

Zheng, Yulong;
Mislang, Anna Rachelle Austria;
Coward, Jermaine;
Cosman, Rasha;
Cooper, Adam;
Underhill, Craig;
Zhu, Jianqing;
Xiong, Jianping;
Jiang, Ou;
Wang, Hong;
Xie, Yanru;
Zhou, Yuefen;
Jin, Xiaoping;
Li, Baiyong;
Wang, Zhongmin Maxwell;
Kwek, Kon Yew;
Xia, Dennis;
Xia, Yu;
Xu, Nong

Publication type:

Article

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2485, doi. 10.1007/s00262-022-03159-8

By:

Loeb, David M.;
Lee, Ji Won;
Morgenstern, Daniel A.;
Samson, Yvan;
Uyttebroeck, Anne;
Lyu, Chuhl Joo;
Van Damme, An;
Nysom, Karsten;
Macy, Margaret E.;
Zorzi, Alexandra P.;
Xiong, Julia;
Pollert, Petra;
Joerg, Ingrid;
Vugmeyster, Yulia;
Ruisi, Mary;
Kang, Hyoung Jin

Publication type:

Article

VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2355, doi. 10.1007/s00262-022-03156-x

By:

Khan, ANM Nazmul H.;
Emmons, Tiffany R.;
Magner, William J.;
Alqassim, Emad;
Singel, Kelly L.;
Ricciuti, Jason;
Eng, Kevin H.;
Odunsi, Kunle;
Tomasi, Thomas B.;
Lee, Kelvin;
Abrams, Scott I.;
Mesa, Circe;
Segal, Brahm H.

Publication type:

Article

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2341, doi. 10.1007/s00262-022-03143-2

By:

Song, Peng;
Li, Wenbin;
Wu, Xiaoxuan;
Qian, Zhirong;
Ying, Jianming;
Gao, Shugeng;
He, Jie

Publication type:

Article

Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 10

Tumour cell-activated platelets modulate the immunological activity of CD4<sup>+</sup>, CD8<sup>+</sup>, and NK cells, which is efficiently antagonized by heparin.

Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.

Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches.

Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.

Immunosuppressive properties of human PD-1 + , PDL-1 + and CD80 + dendritic cells from lymph nodes aspirates of lung cancer patients.

Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells.

The nuclear transportation of PD-L1 and the function in tumor immunity and progression.

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.

Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.

Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma.

CMTM6 as a master regulator of PD-L1.

Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy.

Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.

Correction to: Functional virus‑specific memory T cells survey glioblastoma.

Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood.

Transient 40 °C-shock potentiates cytotoxic responses of Vδ2<sup>+</sup> γδ T cell via HSP70 upregulation.

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials.

Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.

VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma.